217 related articles for article (PubMed ID: 17728024)
1. Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein.
Roy S; Kobinger GP; Lin J; Figueredo J; Calcedo R; Kobasa D; Wilson JM
Vaccine; 2007 Sep; 25(39-40):6845-51. PubMed ID: 17728024
[TBL] [Abstract][Full Text] [Related]
2. Single-dose vaccination of a recombinant parainfluenza virus 5 expressing NP from H5N1 virus provides broad immunity against influenza A viruses.
Li Z; Gabbard JD; Mooney A; Gao X; Chen Z; Place RJ; Tompkins SM; He B
J Virol; 2013 May; 87(10):5985-93. PubMed ID: 23514880
[TBL] [Abstract][Full Text] [Related]
3. Chimpanzee adenovirus vector-based avian influenza vaccine completely protects mice against lethal challenge of H5N1.
Cheng T; Wang X; Song Y; Tang X; Zhang C; Zhang H; Jin X; Zhou D
Vaccine; 2016 Sep; 34(41):4875-4883. PubMed ID: 27576071
[TBL] [Abstract][Full Text] [Related]
4. Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.
Patel A; Gray M; Li Y; Kobasa D; Yao X; Kobinger GP
Vaccine; 2012 Jan; 30(3):626-36. PubMed ID: 22119588
[TBL] [Abstract][Full Text] [Related]
5. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
[TBL] [Abstract][Full Text] [Related]
6. Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine.
Pandey A; Singh N; Vemula SV; Couëtil L; Katz JM; Donis R; Sambhara S; Mittal SK
PLoS One; 2012; 7(3):e33428. PubMed ID: 22432020
[TBL] [Abstract][Full Text] [Related]
7. Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early time.
Vemula SV; Amen O; Katz JM; Donis R; Sambhara S; Mittal SK
Virus Res; 2013 Dec; 178(2):398-403. PubMed ID: 24051000
[TBL] [Abstract][Full Text] [Related]
8. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
[TBL] [Abstract][Full Text] [Related]
9. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
Lei H; Peng X; Jiao H; Zhao D; Ouyang J
Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406
[TBL] [Abstract][Full Text] [Related]
10. A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus.
Chang H; Huang C; Wu J; Fang F; Zhang W; Wang F; Chen Z
Virol J; 2010 Aug; 7():197. PubMed ID: 20727202
[TBL] [Abstract][Full Text] [Related]
11. Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens.
Xue C; Tian G; Chen X; Liu Q; Ma J; Xu S; Li X; Chen H; Cao Y
Virus Res; 2015 Jan; 195():35-42. PubMed ID: 25312452
[TBL] [Abstract][Full Text] [Related]
12. Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice.
Altenburg AF; Magnusson SE; Bosman F; Stertman L; de Vries RD; Rimmelzwaan GF
Clin Exp Immunol; 2017 Oct; 190(1):19-28. PubMed ID: 28665497
[TBL] [Abstract][Full Text] [Related]
13. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
[TBL] [Abstract][Full Text] [Related]
14. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF
J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985
[TBL] [Abstract][Full Text] [Related]
15. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous immunization with recombinant adenovirus expressing influenza A nucleoprotein protects mice against lethal viral challenge.
Hashem A; Jaentschke B; Gravel C; Tocchi M; Doyle T; Rosu-Myles M; He R; Li X
Hum Vaccin Immunother; 2012 Apr; 8(4):425-30. PubMed ID: 22370512
[TBL] [Abstract][Full Text] [Related]
17. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization.
Gao W; Soloff AC; Lu X; Montecalvo A; Nguyen DC; Matsuoka Y; Robbins PD; Swayne DE; Donis RO; Katz JM; Barratt-Boyes SM; Gambotto A
J Virol; 2006 Feb; 80(4):1959-64. PubMed ID: 16439551
[TBL] [Abstract][Full Text] [Related]
18. Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1.
Tompkins SM; Zhao ZS; Lo CY; Misplon JA; Liu T; Ye Z; Hogan RJ; Wu Z; Benton KA; Tumpey TM; Epstein SL
Emerg Infect Dis; 2007 Mar; 13(3):426-35. PubMed ID: 17552096
[TBL] [Abstract][Full Text] [Related]
19. The virus-induced signaling adaptor molecule enhances DNA-raised immune protection against H5N1 influenza virus infection in mice.
Luo M; Qu X; Pan R; Zhu D; Zhang Y; Wu J; Pan Z
Vaccine; 2011 Mar; 29(14):2561-7. PubMed ID: 21303708
[TBL] [Abstract][Full Text] [Related]
20. IRES-based co-expression of influenza virus conserved genes can promote synergistic antiviral effects both in vitro and in vivo.
Khodamoradi S; Shenagari M; Kheiri MT; Sabahi F; Jamali A; Heidari A; Ashrafkhani B
Arch Virol; 2018 Apr; 163(4):877-886. PubMed ID: 29270718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
